Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Walker, N. J.
Right arrow Articles by Sutter, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, N. J.
Right arrow Articles by Sutter, T. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 395-402, Copyright © 1998 by Oxford University Press


ARTICLES

Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria

NJ Walker, FG Crofts, Y Li, SF Lax, CL Hayes, PT Strickland, GW Lucier and TR Sutter
Department of Environmental Health Sciences, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Knowledge of the response of cytochrome P450 1B1 (CYP1B1) to exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in both humans and rodents is limited. To improve the analysis of CYP1 proteins, specific CYP1B1 and CYP1A1 polypeptides were expressed as hexahistidine-tagged fusion proteins in Escherichia coli, purified to homogeneity and used to produce polyclonal antibodies in rabbits. Immunoblot analyses showed that these antibodies were specific and sensitive, detecting both the human and rat forms of the respective isozymes and exhibiting negligible cross-reactivity between the two known CYP1 subfamilies. We show that CYP1B1, CYP1A1 and CYP1A2 protein levels were induced in the livers of female Sprague-Dawley rats following either acute (single dose of 25 microg TCDD/kg) or chronic (125 ng TCDD/kg/day for 30 weeks) exposure to TCDD. CYP1B1 protein exhibited a dose-response to TCDD that was different from those of CYP1A1 and CYP1A2. CYP1B1 induction appeared to be less sensitive to TCDD exposure, with induction occurring at higher doses of TCDD than that required for induction of CYP1A1 or CYP1A2. Immunohistochemical analysis showed that in animals chronically exposed to TCDD (35 ng/kg/day for 30 weeks), CYP1B1 was induced only in centrilobular hepatocytes, a pattern of expression similar to that of CYP1A1 and CYP1A2. These observations of cellular co- localization of the CYP1 cytochromes in livers of TCDD-treated rats and apparent differences in both protein amounts and dose-response are indicative of both common and unique regulation of CYP1 induction.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. Rahman, S. F. Lax, C. H. Sutter, Q. T. Tran, G. L. Stevens, G. L. Emmert, J. Russo, R. J. Santen, and T. R. Sutter
CYP1B1 Is Not a Major Determinant of the Disposition of Aromatase Inhibitors in Epithelial Cells of Invasive Ductal Carcinoma
Drug Metab. Dispos., May 1, 2008; 36(5): 963 - 970.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. R. Yang, R. M. Pfeiffer, M. Garcia-Closas, D. L. Rimm, J. Lissowska, L. A. Brinton, B. Peplonska, S. M. Hewitt, R. W. Cartun, D. Mandich, et al.
Hormonal Markers in Breast Cancer: Coexpression, Relationship with Pathologic Characteristics, and Risk Factor Associations in a Population-Based Study
Cancer Res., November 1, 2007; 67(21): 10608 - 10617.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. S. Mammen, G. S. Pittman, Y. Li, F. Abou-Zahr, B. A. Bejjani, D. A. Bell, P. T. Strickland, and T. R. Sutter
Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against (-)benzo[a]pyrene-7R-trans-7,8-dihydrodiol
Carcinogenesis, July 1, 2003; 24(7): 1247 - 1255.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. P. Bofinger, L. Feng, L.-H. Chi, J. Love, F. D. Stephen, T. R. Sutter, K. G. Osteen, T. G. Costich, R. E. Batt, S. T. Koury, et al.
Effect of TCDD Exposure on CYP1A1 and CYP1B1 Expression in Explant Cultures of Human Endometrium
Toxicol. Sci., August 1, 2001; 62(2): 299 - 314.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. E. Hudson, B. A. Schulte, T. R. Sutter, and J. S. Norris
Steroid hormones modulate expression of cytochrome P450 enzymes in male hamster reproductive tract and leiomyosarcomas
Carcinogenesis, May 1, 2001; 22(5): 763 - 770.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. M. Wilson and G. A. Reed
Predominant 4-hydroxylation of estradiol by constitutive cytochrome P450s in the female ACI rat liver
Carcinogenesis, February 1, 2001; 22(2): 257 - 263.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
C. R. Jefcoate, J. G. Liehr, R. J. Santen, T. R. Sutter, J. D. Yager, W. Yue, S. J. Santner, R. Tekmal, L. Demers, R. Pauley, et al.
Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 95 - 112.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. P. Knight, T. Primiano, J. D. Groopman, T. W. Kensler, and T. R. Sutter
cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3
Carcinogenesis, July 1, 1999; 20(7): 1215 - 1223.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.